Society Testimony

Testimony to FDA on Testosterone

September 17, 2014

Endocrine Society Testimony to the Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee

"We recommend that treatment with testosterone be limited to men who meet established diagnostic guidelines for hypogonadism,, i.e., men who have clinical manifestations AND consistently low testosterone levels, and that treated patients be monitored as recommended by appropriate guidelines. We also recommend that more data be collected on men of different ages to better establish the serum testosterone thresholds for specific organ-related symptoms and signs, and to determine which clinical manifestations will benefit from replacement testosterone therapy. Finally, we recommend that a large scale, well controlled study be conducted to assess long term cardiovascular and prostate risks associated with testosterone replacement treatment."

arrowRead the Full Testimony

Last Updated:

Policy Communications

Take Action

Make Your Voice Heard

Take Action
Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

ENDO 2020

Maximize Your Savings

Register Today
Bringing together leading experts, researchers, and the most respected clinicians in the field, ENDO represents a convergence of science and practice that highlights and facilitates breakthrough discoveries in the field of endocrinology.

Advance Registration Deadline: February 13, 2020

Bringing together leading experts, researchers, and the most respected clinicians in the field, ENDO represents a convergence of science and practice that highlights and facilitates breakthrough discoveries in the field of endocrinology.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!